Characterization and in vivo assay of chitosan alginate microencapsulation to deliver the combination of HBcAg and HBsAg as a hepatitis B oral vaccine candidate

• Үндсэн зохиолчид: Nurlaili Ekawati (Зохиогч), Mohamad Taufik (Зохиогч), Apon Zaenal Mustopa (Зохиогч), Ari Estuningtyas (Зохиогч), Imelda Rosalyn Sianipar (Зохиогч), Ai Hertati (Зохиогч), Maritsa Nurfatwa (Зохиогч), Djadjat Tisnadjaja (Зохиогч), Tri Isyani Tungga Dewi (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Faculty of Pharmacy, Mahidol University, 2022-09-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Chronic hepatitis B infection is one of main factors of cirrhosis primary cause, which can develop into hepatocellular carcinoma. Medically, there are various disadvantages associated with administering hepatitis B vaccine through injection, include pain, reduced patient compliance, higher productio...